September 16, 2021
Travere Licenses Sparsentan to Vifor Pharma for Commercialization in Europe, Australia, and New Zealand
Read More
September 13, 2021
RARE-X and C-Path Establish New Collaboration for Rare Disease Data Sharing
Read More
September 8, 2021
Albireo Sells Priority Review Voucher (PRV) for $105 Million
Read More
September 8, 2021
Sanofi to Acquire Kadmon for $1.9 Billion, Gaining Approved Therapy for cGVHD
Read More
September 7, 2021
Invitae to Acquire Ciitizen for $325 Million
Read More
September 7, 2021
Moderna and ILCM to Collaborate to Develop mRNA Therapeutic for Crigler-Najjar Syndrome Type 1
Read More
September 7, 2021
NeuExcell Therapeutics Enters Research Collaboration with Spark for Huntington’s Disease Gene Therapy
Read More
September 3, 2021
SOBI Board of Directors Recommends $8.1 Billion Takeover by Private Equity Consortium
Read More
September 2, 2021
Polyphor and EnBiotix Sign Merger Agreement and sale of Inhaled Murepavadin to EnBiotix
Read More
August 31, 2021
VectivBio Acquires Comet, Expanding Rare Metabolic Disease Pipeline
Read More
August 24, 2021
Vertex and Arbor Partner to Develop Novel Ex Vivo Engineered Cell Therapies
Read More
August 24, 2021
Shape and Roche Collaborate to advance AAV-based RNA Editing for Neuroscience and Rare Diseases
Read More
Load More
X